TABLE 1.
Summary of patient cohort information.
| Factor | Cohort |
P-value | |
| Training (N = 261) | Test (N = 87) | ||
| Gender | 0.797 | ||
| Male | 165 | 57 | |
| Female | 96 | 30 | |
| Age (year) | 0.050 | ||
| <65 | 117 | 27 | |
| ≥65 | 141 | 59 | |
| Not available | 3 | 1 | |
| T | 0.571 | ||
| T1–2 | 65 | 25 | |
| T3–4 | 196 | 62 | |
| N | 0.852 | ||
| N0 | 79 | 30 | |
| N1–3 | 177 | 56 | |
| Nx | 4 | 1 | |
| Not available | 1 | 0 | |
| M | 0.091 | ||
| M0 | 235 | 73 | |
| M1 | 17 | 6 | |
| Mx | 9 | 8 | |
| Pathological stage | 0.803 | ||
| I–II | 123 | 39 | |
| III–VI | 138 | 48 | |
| Histological type | 0.599 | ||
| Diffuse type | 45 | 13 | |
| Mucinous type | 16 | 3 | |
| Not otherwise specified | 141 | 49 | |
| Papillary type | 4 | 1 | |
| Signet ring type | 8 | 2 | |
| Tubular type | 47 | 18 | |
| Not available | 0 | 1 | |
| Microsatellite | 0.904 | ||
| MSI-H | 46 | 15 | |
| MSS-L | 41 | 12 | |
| MSS | 173 | 60 | |
| Not available | 1 | 0 | |
| Grade | 0.840 | ||
| G1 | 5 | 3 | |
| G2 | 93 | 30 | |
| G3 | 157 | 52 | |
| Gx | 6 | 2 | |
MSI-H, microsatellite instability-high; MSI-L, microsatellite instability-low; MSS, microsatellite stability.